$23,66
-$0,43(-1,78 %)
*Data last updated: 2026-05-23 08:04 (UTC+8)
As of 2026-05-23 08:04, Hims & Hers Health, Inc. (HIMS) is priced at $23,66, with a total market cap of $5,21B, a P/E ratio of 56,90, and a dividend yield of 0,00 %. Today, the stock price fluctuated between $23,00 and $24,53. The current price is 2,86 % above the day's low and 3,54 % below the day's high, with a trading volume of 13,07M. Over the past 52 weeks, HIMS has traded between $22,60 to $24,53, and the current price is -3,54 % away from the 52-week high.
HIMS Key Stats
Yesterday's Close$24,01
Market Cap$5,21B
Volumen13,07M
P/E Ratio56,90
Dividend Yield (TTM)0,00 %
Diluted EPS (TTM)0,06
Net Income (FY)$128,36M
Revenue (FY)$2,34B
Earnings Date2026-08-10
EPS Estimate0,01
Revenue Estimate$688,57M
Shares Outstanding217,18M
Beta (1Y)2.423
About HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
SectorHealthcare
IndustryMedical - Equipment & Services
CEOAndrew Dudum
HeadquartersSan Francisco,CA,US
Official Websitehttps://www.forhims.com
Employees (FY)2,44K
Average Revenue (1Y)$961,35K
Net Income per Employee$52,56K
Erfahren Sie mehr über Hims & Hers Health, Inc. (HIMS)
Blogs
Gate Stock Token Update: Unbefristete Kontrakte auf DRAM, HIMS, SHLD, IWM und FLNC jetzt verfügbarGate’s Contracts Stock Zone hat am 18. Mai fünf neue unbefristete Kontrakte – DRAM, HIMS, SHLD, IWM und FLNC – eingeführt. Diese Kontrakte werden in USDT abgerechnet und ermöglichen einen Hebel von 1- bis 20-fach. In diesem Artikel erhalten Sie einen Überblick über die jeweiligen Investitionsgründe und den Markthintergrund dieser fünf neuen Assets.2026-05-19

Hims & Hers Health (HIMS) Aktienanalyse: Ist jetzt der richtige Zeitpunkt, um in dieses digitale Gesundheitsunternehmen zu investieren?Im vergangenen Jahr erreichte der Aktienkurs eines Unternehmens einen Höchststand von 72,98 US-Dollar und fiel auf ein Tief von 23,97 US-Dollar. Der aktuelle Kurs liegt bei etwa 32 US-Dollar.2026-01-16

Hims & Hers Health, Inc. (HIMS) FAQ
What's the stock price of Hims & Hers Health, Inc. (HIMS) today?
x
Hims & Hers Health, Inc. (HIMS) is currently trading at $23,66, with a 24h change of -1,78 %. The 52-week trading range is $22,60–$24,53.
What are the 52-week high and low prices for Hims & Hers Health, Inc. (HIMS)?
x
What is the price-to-earnings (P/E) ratio of Hims & Hers Health, Inc. (HIMS)? What does it indicate?
x
What is the market cap of Hims & Hers Health, Inc. (HIMS)?
x
What is the most recent quarterly earnings per share (EPS) for Hims & Hers Health, Inc. (HIMS)?
x
Should you buy or sell Hims & Hers Health, Inc. (HIMS) now?
x
What factors can affect the stock price of Hims & Hers Health, Inc. (HIMS)?
x
How to buy Hims & Hers Health, Inc. (HIMS) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

















































































































































































































































































































































































































































